Esaú Martinez1, Jordi Martorell2, Vincent Riambau3. 1. Hospital de Mataró, Consorci Sanitari del Maresme, Barcelona, Spain; Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. 2. IQS School of Engineering, Universitat Ramon Llull, Barcelona, Spain. Electronic address: jordi.martorell@iqs.edu. 3. Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
Abstract
BACKGROUND: Carotid artery atherosclerotic stenosis is a preventable major cause of stroke, but there is still a need for definition of high-risk plaque in asymptomatic patients who might benefit from interventional therapies. Several image markers are recommended to characterize unstable plaques. The measurement of serum biomarkers is a promising method to assist in decision making, but the lack of robust evidence in the carotid environment burdens their potential as a standard of care. The goal of this review was to offer an updated state-of-the-art study of available serum biomarkers with clinical implications, with focus on those that may predict carotid symptom development. METHODS: The Cochrane Library and MEDLINE databases were searched (all until September 2018) for studies on carotid plaque and serum biomarkers of atherosclerosis. Nonhuman, basic science, and histology studies were excluded, focusing on clinical studies. Selected abstracts were screened to include the most relevant articles on atherosclerotic plaque presence, progression, instability or symptom development. RESULTS: Some well-established biomarkers for coronary disease are not relevant to carotid atherosclerosis and other inflammatory biomarkers, lipids, interleukins, homocysteine, and adipokines may be useful in quantifying carotid disease-related risk. Some serum biomarkers combined with image features may assist vascular specialists in selecting patients at high risk for stroke and in need of intervention. CONCLUSIONS: Prospective studies applying a combination of biomarkers are essential to prove clinical usefulness.
BACKGROUND: Carotid artery atherosclerotic stenosis is a preventable major cause of stroke, but there is still a need for definition of high-risk plaque in asymptomatic patients who might benefit from interventional therapies. Several image markers are recommended to characterize unstable plaques. The measurement of serum biomarkers is a promising method to assist in decision making, but the lack of robust evidence in the carotid environment burdens their potential as a standard of care. The goal of this review was to offer an updated state-of-the-art study of available serum biomarkers with clinical implications, with focus on those that may predict carotid symptom development. METHODS: The Cochrane Library and MEDLINE databases were searched (all until September 2018) for studies on carotid plaque and serum biomarkers of atherosclerosis. Nonhuman, basic science, and histology studies were excluded, focusing on clinical studies. Selected abstracts were screened to include the most relevant articles on atherosclerotic plaque presence, progression, instability or symptom development. RESULTS: Some well-established biomarkers for coronary disease are not relevant to carotid atherosclerosis and other inflammatory biomarkers, lipids, interleukins, homocysteine, and adipokines may be useful in quantifying carotid disease-related risk. Some serum biomarkers combined with image features may assist vascular specialists in selecting patients at high risk for stroke and in need of intervention. CONCLUSIONS: Prospective studies applying a combination of biomarkers are essential to prove clinical usefulness.
Authors: Wen Shen; Chao Gao; Ramon Cueto; Lu Liu; Hangfei Fu; Ying Shao; William Y Yang; Pu Fang; Eric T Choi; Qinghua Wu; Xiaofeng Yang; Hong Wang Journal: Redox Biol Date: 2019-09-12 Impact factor: 11.799
Authors: Ricarda D Stauss; Gerrit M Grosse; Lavinia Neubert; Christine S Falk; Danny Jonigk; Mark P Kühnel; Maria M Gabriel; Ramona Schuppner; Ralf Lichtinghagen; Mathias Wilhelmi; Karin Weissenborn; Claudia Schrimpf Journal: Sci Rep Date: 2020-12-15 Impact factor: 4.379
Authors: Vadim V Klimontov; Elena A Koroleva; Rustam S Khapaev; Anton I Korbut; Alexander P Lykov Journal: J Clin Med Date: 2021-12-24 Impact factor: 4.241